TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-masked, Multicenter, Laser-controlled Phase III Study Assessing the Efficacy and Safety of Ranibizumab (Intravitreal Injections) as Adjunctive and Mono-therapy in Patients With Visual Impairment Due to Diabetic Macular Edema
Brief Summary: CRFB002D2301: The core study was designed to confirm the efficacy and safety of ranibizumab (0.5 mg) as adjunctive therapy when added to laser photocoagulation and/or mono-therapy in patients with visual impairment due to diabetic macular edema.

CRFB002D2301E1: A 24 month open-label extension study for participants who completed the 12 month core study evaluated the long-term safety and efficacy of ranibizumab (0.5 mg) as symptomatic treatment for visual impairment due to diabetic macular edema.


Options:
A: Arm Label: Modified Early Treatment Diabetic Retinopathy Study (ETDRS); Type: ACTIVE_COMPARATOR; Interventions: Procedure: modified-ETDRS photocoagulation | Arm Label: Mild Macular Grid (MMG); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Mild Macular Grid photocoagulation | Intervention Type: PROCEDURE; Name: modified-ETDRS photocoagulation; Assigned to Arm(s): Modified Early Treatment Diabetic Retinopathy Study (ETDRS) | Intervention Type: PROCEDURE; Name: Mild Macular Grid photocoagulation; Assigned to Arm(s): Mild Macular Grid (MMG)
B: Arm Label: MNPDR; Type: N/A; Interventions: N/A
C: Arm Label: Ranibizumab 0.3 mg; Type: EXPERIMENTAL; Interventions: Drug: Ranibizumab 0.3 mg | Arm Label: Ranibizumab 0.5 mg; Type: EXPERIMENTAL; Interventions: Drug: Ranibizumab 0.5 mg | Arm Label: Sham injection; Type: SHAM_COMPARATOR; Interventions: Drug: Sham injection | Intervention Type: DRUG; Name: Ranibizumab 0.3 mg; Assigned to Arm(s): Ranibizumab 0.3 mg | Intervention Type: DRUG; Name: Ranibizumab 0.5 mg; Assigned to Arm(s): Ranibizumab 0.5 mg | Intervention Type: DRUG; Name: Sham injection; Assigned to Arm(s): Sham injection
D: Arm Label: Ranibizumab 0.5 mg; Type: EXPERIMENTAL; Interventions: Drug: Ranibizumab, Procedure: Laser, Procedure: Sham laser | Arm Label: Ranibizumab 0.5 mg + laser; Type: EXPERIMENTAL; Interventions: Drug: Ranibizumab, Procedure: Laser | Arm Label: Laser; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ranibizumab, Procedure: Laser, Drug: Sham to ranibizumab | Intervention Type: DRUG; Name: Ranibizumab; Assigned to Arm(s): Laser, Ranibizumab 0.5 mg, Ranibizumab 0.5 mg + laser | Intervention Type: PROCEDURE; Name: Laser; Assigned to Arm(s): Laser, Ranibizumab 0.5 mg, Ranibizumab 0.5 mg + laser | Intervention Type: PROCEDURE; Name: Sham laser; Assigned to Arm(s): Ranibizumab 0.5 mg | Intervention Type: DRUG; Name: Sham to ranibizumab; Assigned to Arm(s): Laser

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Participative Rehabilitation Process Management "Stroke in Saxony-Anhalt"
Brief Summary: Primary objective of this study is to determine whether a case management of stroke patients after discharge to home or to nursing home results in improving physical and cognitive capacity one year after discharge.


Options:
A: Arm Label: Tai chi program via Telerehabilitation; Type: EXPERIMENTAL; Interventions: Behavioral: Tai Chi based exercise program | Arm Label: Tai chi program via home visits; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Tai Chi based exercise program | Intervention Type: BEHAVIORAL; Name: Tai Chi based exercise program; Assigned to Arm(s): Tai chi program via Telerehabilitation, Tai chi program via home visits
B: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: SCM; Type: EXPERIMENTAL; Interventions: Other: SCM | Arm Label: SCM and VSSP; Type: EXPERIMENTAL; Interventions: Other: SCM and VSSP | Intervention Type: OTHER; Name: SCM; Assigned to Arm(s): SCM | Intervention Type: OTHER; Name: SCM and VSSP; Assigned to Arm(s): SCM and VSSP
C: Arm Label: Tele-visit Group; Type: EXPERIMENTAL; Interventions: Behavioral: TR intervention, Behavioral: In-home messaging device. | Arm Label: Usual Care Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: TR intervention; Assigned to Arm(s): Tele-visit Group | Intervention Type: BEHAVIORAL; Name: In-home messaging device.; Assigned to Arm(s): Tele-visit Group | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual Care Group
D: Arm Label: Case management; Type: EXPERIMENTAL; Interventions: Behavioral: Case management | Arm Label: usual care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Case management | Intervention Type: BEHAVIORAL; Name: Case management; Assigned to Arm(s): Case management | Intervention Type: BEHAVIORAL; Name: Case management; Assigned to Arm(s): usual care

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Participative Rehabilitation Process Management "Stroke in Saxony-Anhalt"
Brief Summary: Primary objective of this study is to determine whether a case management of stroke patients after discharge to home or to nursing home results in improving physical and cognitive capacity one year after discharge.


Options:
A: Arm Label: Navigation Group; Type: EXPERIMENTAL; Interventions: Behavioral: PROTECT DC | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: PROTECT DC; Assigned to Arm(s): Navigation Group
B: Arm Label: Standard Care, Organized Discharge; Type: PLACEBO_COMPARATOR; Interventions: Other: Video Arm | Arm Label: Video Arm, Standard Discharge; Type: EXPERIMENTAL; Interventions: Other: Video Arm | Intervention Type: OTHER; Name: Video Arm; Assigned to Arm(s): Standard Care, Organized Discharge, Video Arm, Standard Discharge
C: Arm Label: Intervention arm; Type: EXPERIMENTAL; Interventions: Behavioral: Instruction in physical training program | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Instruction in physical training program; Assigned to Arm(s): Intervention arm
D: Arm Label: Case management; Type: EXPERIMENTAL; Interventions: Behavioral: Case management | Arm Label: usual care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Case management | Intervention Type: BEHAVIORAL; Name: Case management; Assigned to Arm(s): Case management | Intervention Type: BEHAVIORAL; Name: Case management; Assigned to Arm(s): usual care

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Quality Malaria Case Management In Under- Fives In Primary Health Care (Phc) Institutions In Bagamoyo And Kibaha Districts Of Coastal Tanzania:a Multicomponent Controlled Intervention Study
Brief Summary: General objective: To improve the quality of fever case management in children in government health facilities in Tanzania Hypothesis:The training of health workers, as well as provision, training and use of microscopes for malaria diagnosis will improve the treatment of clinical episodes of fever in children while reducing the amount and costs of drugs


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: Clinical algorithm and microscopy diagnosis of malaria | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Clinical algorithm and microscopy diagnosis of malaria | Arm Label: 3; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Clinical algorithm and microscopy diagnosis of malaria; Assigned to Arm(s): 1, 2
B: Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Microscopy | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Clinical diagnosis for malaria | Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: Rapid diagnostic test | Intervention Type: PROCEDURE; Name: Rapid diagnostic test; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Microscopy; Assigned to Arm(s): 2 | Intervention Type: PROCEDURE; Name: Clinical diagnosis for malaria; Assigned to Arm(s): 3
C: Arm Label: Field microscopy; Type: OTHER; Interventions: Device: Field microscopy and Paracheck Pf® | Arm Label: Paracheck Pf® device; Type: OTHER; Interventions: Device: Field microscopy and Paracheck Pf® | Arm Label: Presumptive diagnostic method; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Field microscopy and Paracheck Pf®; Assigned to Arm(s): Field microscopy, Paracheck Pf® device
D: Arm Label: Observation; Type: N/A; Interventions: Drug: Artesunate + Amodiaquine Fixed Dose Combination (CoArsucam) | Intervention Type: DRUG; Name: Artesunate + Amodiaquine Fixed Dose Combination (CoArsucam); Assigned to Arm(s): Observation

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy and Safety of Etanercept in Active Rheumatoid Arthritis Despite Methotrexate Therapy in Japan
Brief Summary: Multi-center, parallel-group, randomized, open control study. All patients will be selected to two treatment groups.

1. Etanercept alone treatment group (25mg, twice/week, s.c.)
2. Etanercept combined with MTX group (25mg, twice/week, s.c.+MTX 6-8mg/week)


Options:
A: Arm Label: Group 1: Placebo + Methotrexate; Type: EXPERIMENTAL; Interventions: Drug: Placebo injections, Drug: Methotrexate capsules, Biological: Golimumab 50 mg injections, Biological: Golimumab 100 mg injections | Arm Label: Group 2: Golimumab 100 mg + Placebo; Type: EXPERIMENTAL; Interventions: Drug: Placebo capsules, Drug: Methotrexate capsules, Biological: Golimumab 50 mg injections, Biological: Golimumab 100 mg injections | Arm Label: Group 3: Golimumab 50 mg + Methotrexate; Type: EXPERIMENTAL; Interventions: Drug: Methotrexate capsules, Biological: Golimumab 50 mg injections, Biological: Golimumab 100 mg injections | Arm Label: Group 4: Golimumab 100 mg + Methotrexate; Type: EXPERIMENTAL; Interventions: Drug: Methotrexate capsules, Biological: Golimumab 50 mg injections, Biological: Golimumab 100 mg injections | Intervention Type: DRUG; Name: Placebo injections; Assigned to Arm(s): Group 1: Placebo + Methotrexate | Intervention Type: DRUG; Name: Placebo capsules; Assigned to Arm(s): Group 2: Golimumab 100 mg + Placebo | Intervention Type: DRUG; Name: Methotrexate capsules; Assigned to Arm(s): Group 1: Placebo + Methotrexate, Group 2: Golimumab 100 mg + Placebo, Group 3: Golimumab 50 mg + Methotrexate, Group 4: Golimumab 100 mg + Methotrexate | Intervention Type: BIOLOGICAL; Name: Golimumab 50 mg injections; Assigned to Arm(s): Group 1: Placebo + Methotrexate, Group 2: Golimumab 100 mg + Placebo, Group 3: Golimumab 50 mg + Methotrexate, Group 4: Golimumab 100 mg + Methotrexate | Intervention Type: BIOLOGICAL; Name: Golimumab 100 mg injections; Assigned to Arm(s): Group 1: Placebo + Methotrexate, Group 2: Golimumab 100 mg + Placebo, Group 3: Golimumab 50 mg + Methotrexate, Group 4: Golimumab 100 mg + Methotrexate
B: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: conventional DMARD combination | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Biological: MTX plus anti-TNF | Intervention Type: DRUG; Name: conventional DMARD combination; Assigned to Arm(s): A | Intervention Type: BIOLOGICAL; Name: MTX plus anti-TNF; Assigned to Arm(s): B
C: Arm Label: ETN Alone; Type: ACTIVE_COMPARATOR; Interventions: Drug: ETN Alone | Arm Label: ETN+MTX; Type: ACTIVE_COMPARATOR; Interventions: Drug: ETN+MTX | Intervention Type: DRUG; Name: ETN Alone; Assigned to Arm(s): ETN Alone | Intervention Type: DRUG; Name: ETN+MTX; Assigned to Arm(s): ETN+MTX
D: Intervention Type: DRUG; Name: Etanercept; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy and Safety of Etanercept in Active Rheumatoid Arthritis Despite Methotrexate Therapy in Japan
Brief Summary: Multi-center, parallel-group, randomized, open control study. All patients will be selected to two treatment groups.

1. Etanercept alone treatment group (25mg, twice/week, s.c.)
2. Etanercept combined with MTX group (25mg, twice/week, s.c.+MTX 6-8mg/week)


Options:
A: Arm Label: ETN Alone; Type: ACTIVE_COMPARATOR; Interventions: Drug: ETN Alone | Arm Label: ETN+MTX; Type: ACTIVE_COMPARATOR; Interventions: Drug: ETN+MTX | Intervention Type: DRUG; Name: ETN Alone; Assigned to Arm(s): ETN Alone | Intervention Type: DRUG; Name: ETN+MTX; Assigned to Arm(s): ETN+MTX
B: Intervention Type: DRUG; Name: CDP870; Assigned to Arm(s): N/A
C: Arm Label: Methotrexate; Type: ACTIVE_COMPARATOR; Interventions: Biological: tocilizumab, Drug: methotrexate, Biological: 23-Valent Pneumococcal Polysaccharide Vaccine, Biological: Tetanus Toxoid Adsorbed Vaccine | Arm Label: Tocilizumab + Methotrexate; Type: EXPERIMENTAL; Interventions: Biological: tocilizumab, Drug: methotrexate, Biological: 23-Valent Pneumococcal Polysaccharide Vaccine, Biological: Tetanus Toxoid Adsorbed Vaccine | Intervention Type: BIOLOGICAL; Name: tocilizumab; Assigned to Arm(s): Methotrexate, Tocilizumab + Methotrexate | Intervention Type: DRUG; Name: methotrexate; Assigned to Arm(s): Methotrexate, Tocilizumab + Methotrexate | Intervention Type: BIOLOGICAL; Name: 23-Valent Pneumococcal Polysaccharide Vaccine; Assigned to Arm(s): Methotrexate, Tocilizumab + Methotrexate | Intervention Type: BIOLOGICAL; Name: Tetanus Toxoid Adsorbed Vaccine; Assigned to Arm(s): Methotrexate, Tocilizumab + Methotrexate
D: Arm Label: Golimumab (CNTO 148) with Methotrexate (MTX); Type: EXPERIMENTAL; Interventions: Drug: Golimumab, Drug: MTX | Arm Label: Infliximab with MTX; Type: EXPERIMENTAL; Interventions: Drug: MTX, Drug: Infliximab | Arm Label: Placebo with MTX; Type: PLACEBO_COMPARATOR; Interventions: Drug: MTX, Drug: Placebo | Intervention Type: DRUG; Name: Golimumab; Assigned to Arm(s): Golimumab (CNTO 148) with Methotrexate (MTX) | Intervention Type: DRUG; Name: MTX; Assigned to Arm(s): Golimumab (CNTO 148) with Methotrexate (MTX), Infliximab with MTX, Placebo with MTX | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo with MTX | Intervention Type: DRUG; Name: Infliximab; Assigned to Arm(s): Infliximab with MTX

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy and Safety of Etanercept in Active Rheumatoid Arthritis Despite Methotrexate Therapy in Japan
Brief Summary: Multi-center, parallel-group, randomized, open control study. All patients will be selected to two treatment groups.

1. Etanercept alone treatment group (25mg, twice/week, s.c.)
2. Etanercept combined with MTX group (25mg, twice/week, s.c.+MTX 6-8mg/week)


Options:
A: Arm Label: ETN Alone; Type: ACTIVE_COMPARATOR; Interventions: Drug: ETN Alone | Arm Label: ETN+MTX; Type: ACTIVE_COMPARATOR; Interventions: Drug: ETN+MTX | Intervention Type: DRUG; Name: ETN Alone; Assigned to Arm(s): ETN Alone | Intervention Type: DRUG; Name: ETN+MTX; Assigned to Arm(s): ETN+MTX
B: Arm Label: Open Label Infliximab + Methotrexate; Type: EXPERIMENTAL; Interventions: Biological: Infliximab + methotrexate (MTX) | Intervention Type: BIOLOGICAL; Name: Infliximab + methotrexate (MTX); Assigned to Arm(s): Open Label Infliximab + Methotrexate
C: Arm Label: CDP870 200mg; Type: EXPERIMENTAL; Interventions: Drug: CDP870 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo of CDP870 | Intervention Type: DRUG; Name: CDP870; Assigned to Arm(s): CDP870 200mg | Intervention Type: DRUG; Name: Placebo of CDP870; Assigned to Arm(s): Placebo
D: Intervention Type: DRUG; Name: CDP870; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy and Safety of Etanercept in Active Rheumatoid Arthritis Despite Methotrexate Therapy in Japan
Brief Summary: Multi-center, parallel-group, randomized, open control study. All patients will be selected to two treatment groups.

1. Etanercept alone treatment group (25mg, twice/week, s.c.)
2. Etanercept combined with MTX group (25mg, twice/week, s.c.+MTX 6-8mg/week)


Options:
A: Intervention Type: DRUG; Name: CDP870; Assigned to Arm(s): N/A
B: Arm Label: ETN Alone; Type: ACTIVE_COMPARATOR; Interventions: Drug: ETN Alone | Arm Label: ETN+MTX; Type: ACTIVE_COMPARATOR; Interventions: Drug: ETN+MTX | Intervention Type: DRUG; Name: ETN Alone; Assigned to Arm(s): ETN Alone | Intervention Type: DRUG; Name: ETN+MTX; Assigned to Arm(s): ETN+MTX
C: Arm Label: CDP870 200mg; Type: EXPERIMENTAL; Interventions: Drug: CDP870 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo of CDP870 | Intervention Type: DRUG; Name: CDP870; Assigned to Arm(s): CDP870 200mg | Intervention Type: DRUG; Name: Placebo of CDP870; Assigned to Arm(s): Placebo
D: Arm Label: Sequence 1; Type: EXPERIMENTAL; Interventions: Drug: CP-690,550 | Arm Label: Sequence 2; Type: EXPERIMENTAL; Interventions: Drug: CP-690,550 | Arm Label: Sequence 3; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: CP-690,550 | Arm Label: Sequence 4; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: CP-690,550 | Intervention Type: DRUG; Name: CP-690,550; Assigned to Arm(s): Sequence 1 | Intervention Type: DRUG; Name: CP-690,550; Assigned to Arm(s): Sequence 2 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Sequence 3 | Intervention Type: DRUG; Name: CP-690,550; Assigned to Arm(s): Sequence 3 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Sequence 4 | Intervention Type: DRUG; Name: CP-690,550; Assigned to Arm(s): Sequence 4

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Seniors Health and Activity Research Program-Pilot
Brief Summary: The purpose of this pilot study is to develop and conduct well-designed trial to assess whether a multi-factorial intervention involving physical activity and cognitive training reduces the risk of significant cognitive decline in older individuals.


Options:
A: Arm Label: Exercise Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise Intervention | Arm Label: Exercise Control group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise Control | Intervention Type: BEHAVIORAL; Name: Exercise Intervention; Assigned to Arm(s): Exercise Intervention Group | Intervention Type: BEHAVIORAL; Name: Exercise Control; Assigned to Arm(s): Exercise Control group
B: Arm Label: Non-action video game training; Type: EXPERIMENTAL; Interventions: Behavioral: Experimental: Non-action video game training | Arm Label: Non-cognitive video game training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active Comparator: Non-cognitive video game training | Intervention Type: BEHAVIORAL; Name: Experimental: Non-action video game training; Assigned to Arm(s): Non-action video game training | Intervention Type: BEHAVIORAL; Name: Active Comparator: Non-cognitive video game training; Assigned to Arm(s): Non-cognitive video game training
C: Arm Label: Physical Activity Training; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Activity Training | Arm Label: Cognitive Training; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Training | Arm Label: Combined Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Activity Training, Behavioral: Cognitive Training | Arm Label: Healthy Aging Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Healthy Aging Education | Intervention Type: BEHAVIORAL; Name: Physical Activity Training; Assigned to Arm(s): Combined Intervention, Physical Activity Training | Intervention Type: BEHAVIORAL; Name: Cognitive Training; Assigned to Arm(s): Cognitive Training, Combined Intervention | Intervention Type: BEHAVIORAL; Name: Healthy Aging Education; Assigned to Arm(s): Healthy Aging Education
D: Arm Label: Non-action video game training; Type: EXPERIMENTAL; Interventions: Other: Non-action video game training | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Non-action video game training; Assigned to Arm(s): Non-action video game training

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Seniors Health and Activity Research Program-Pilot
Brief Summary: The purpose of this pilot study is to develop and conduct well-designed trial to assess whether a multi-factorial intervention involving physical activity and cognitive training reduces the risk of significant cognitive decline in older individuals.


Options:
A: Arm Label: Aerobic exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Group 1, Behavioral: Group 2 | Arm Label: Stretching/toning; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Group 3, Behavioral: Group 4 | Arm Label: Computer-based mental activity training; Type: EXPERIMENTAL; Interventions: Behavioral: Group 1, Behavioral: Group 3 | Arm Label: Educational DVD training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Group 2, Behavioral: Group 4 | Intervention Type: BEHAVIORAL; Name: Group 1; Assigned to Arm(s): Aerobic exercise, Computer-based mental activity training | Intervention Type: BEHAVIORAL; Name: Group 2; Assigned to Arm(s): Aerobic exercise, Educational DVD training | Intervention Type: BEHAVIORAL; Name: Group 3; Assigned to Arm(s): Computer-based mental activity training, Stretching/toning | Intervention Type: BEHAVIORAL; Name: Group 4; Assigned to Arm(s): Educational DVD training, Stretching/toning
B: Arm Label: Physical Activity Training; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Activity Training | Arm Label: Cognitive Training; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Training | Arm Label: Combined Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Activity Training, Behavioral: Cognitive Training | Arm Label: Healthy Aging Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Healthy Aging Education | Intervention Type: BEHAVIORAL; Name: Physical Activity Training; Assigned to Arm(s): Combined Intervention, Physical Activity Training | Intervention Type: BEHAVIORAL; Name: Cognitive Training; Assigned to Arm(s): Cognitive Training, Combined Intervention | Intervention Type: BEHAVIORAL; Name: Healthy Aging Education; Assigned to Arm(s): Healthy Aging Education
C: Arm Label: Exercise Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise Intervention | Arm Label: Exercise Control group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise Control | Intervention Type: BEHAVIORAL; Name: Exercise Intervention; Assigned to Arm(s): Exercise Intervention Group | Intervention Type: BEHAVIORAL; Name: Exercise Control; Assigned to Arm(s): Exercise Control group
D: Arm Label: cognitive training; Type: EXPERIMENTAL; Interventions: Device: CogniFit Personal Coach® | Intervention Type: DEVICE; Name: CogniFit Personal Coach®; Assigned to Arm(s): cognitive training

Answer: B